| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1146/ANNUREV.IY.13.040195.001143 |
| P698 | PubMed publication ID | 7612220 |
| P2093 | author name string | Todd JA | |
| Peterson LB | |||
| Wicker LS | |||
| P304 | page(s) | 179-200 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Annual Review of Immunology | Q567362 |
| P1476 | title | Genetic control of autoimmune diabetes in the NOD mouse | |
| P478 | volume | 13 |
| Q27320513 | A bispecific protein capable of engaging CTLA-4 and MHCII protects non-obese diabetic mice from autoimmune diabetes |
| Q74825850 | A defect in central tolerance in NOD mice |
| Q42518903 | A locus affecting immunoglobulin isotype selection (Igis1) maps to the MHC region in C57BL, BALB/c and NOD mice |
| Q33857826 | A new animal model for relapsing polychondritis, induced by cartilage matrix protein (matrilin-1). |
| Q39792475 | A non-MHC locus essential for autoimmune type I diabetes in the Komeda Diabetes-Prone rat |
| Q35170270 | A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes |
| Q34172203 | Aberrant endometrial features of pregnancy in diabetic NOD mice. |
| Q33857220 | Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus |
| Q36912209 | Accelerated type 1 diabetes induction in mice by adoptive transfer of diabetogenic CD4+ T cells |
| Q37221573 | Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease |
| Q38135862 | Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse |
| Q53889126 | Allelic variation in class I K gene as candidate for a second component of MHC-linked susceptibility to type 1 diabetes in non-obese diabetic mice. |
| Q25257361 | Alterations of renal phenotype and gene expression profiles due to protein overload in NOD-related mouse strains |
| Q36401332 | Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response |
| Q37369887 | Animal models of human type 1 diabetes. |
| Q34424442 | Antigen-Experienced CD4lo T Cells Are Linked to Deficient Contraction of the Immune Response in Autoimmune Diabetes |
| Q36366219 | Aod2, the locus controlling development of atrophy in neonatal thymectomy-induced autoimmune ovarian dysgenesis, co-localizes with Il2, Fgfb, and Idd3 |
| Q28389398 | Apoptosis of NOD.H2 h4 thyrocytes by low concentrations of iodide is associated with impaired control of oxidative stress |
| Q36554041 | Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region |
| Q37089400 | Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice |
| Q38358439 | Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. |
| Q30445055 | Autoimmune orchitis, epididymitis, and vasitis are immunogenetically distinct lesions. |
| Q81066786 | Autoimmunity and type I diabetes |
| Q32123429 | Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction |
| Q36367653 | B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice |
| Q41079213 | Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: similarity to the major histocompatibility complex class II I-A(g)7 protein of non-obese diabetic mice |
| Q35107621 | Blockade of the programmed death-1 (PD1) pathway undermines potent genetic protection from type 1 diabetes |
| Q36369438 | CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes |
| Q56908828 | CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes |
| Q37496758 | CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L. |
| Q34505844 | CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients. |
| Q55041970 | Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. |
| Q34014524 | Cathepsin L is essential for onset of autoimmune diabetes in NOD mice |
| Q28573498 | Cblb is a major susceptibility gene for rat type 1 diabetes mellitus |
| Q53969367 | Cell-intrinsic effects of non-MHC NOD genes on dendritic cell generation in vivo. |
| Q36148399 | Cellular and genetic mechanisms of self tolerance and autoimmunity |
| Q37689425 | Checkpoints in the progression of autoimmune disease: lessons from diabetes models |
| Q42474483 | Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus |
| Q35852428 | Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice |
| Q53851134 | Conditioning the genome identifies additional diabetes resistance loci in Type I diabetes resistant NOR/Lt mice. |
| Q31666533 | Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping |
| Q24797435 | Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetes |
| Q37557466 | Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models |
| Q44325323 | Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice |
| Q36506677 | Current and future immunomodulation strategies to restore tolerance in autoimmune diseases |
| Q79074342 | Cutting Edge: Diabetes-Associated Quantitative Trait Locus, Idd4, Is Responsible for the IL-12p40 Overexpression Defect in Nonobese Diabetic (NOD) Mice |
| Q36649589 | Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunization |
| Q35329213 | Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade |
| Q61795828 | DLA class II risk haplotypes for autoimmune diseases in the bearded collie offer insight to autoimmunity signatures across dog breeds |
| Q34651934 | Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse |
| Q53623250 | Deregulated stress system in non-obese diabetic lymphocyte. |
| Q41772561 | Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cells |
| Q35851189 | Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers |
| Q35101430 | Development of type 1 diabetes mellitus in nonobese diabetic mice follows changes in thymocyte and peripheral T lymphocyte transcriptional activity |
| Q35571875 | Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice |
| Q36751632 | Dissecting genetic control of autoimmunity in NOD congenic mice |
| Q34142507 | Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background |
| Q27324275 | Double negative (CD3+ 4- 8-) TCR alphabeta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes |
| Q37359000 | Dysrulation of T cell peripheral tolerance in type 1 diabetes |
| Q46942911 | ESI mass spectrometric exploration of selective recognition of G-quadruplex in c-myb oncogene promoter using a novel flexible cyclic polyamide |
| Q39025801 | Early differences in islets from prediabetic NOD mice: combined microarray and proteomic analysis |
| Q30874892 | Early over expression of messenger RNA for multiple genes, including insulin, in the Pancreatic Lymph Nodes of NOD mice is associated with Islet Autoimmunity |
| Q36280801 | Engineering protein for X-ray crystallography: the murine Major Histocompatibility Complex class II molecule I-Ad |
| Q77802794 | Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity |
| Q33869575 | Establishment of an embryonic stem (ES) cell line derived from a non-obese diabetic (NOD) mouse: in vivo differentiation into lymphocytes and potential for germ line transmission |
| Q37385806 | Evidence for oligogenic inheritance of type 1 diabetes in a large Bedouin Arab family |
| Q35688672 | Evidence that MHC I-E dampens thyroid autoantibodies and prevents spreading to a second thyroid autoantigen in I-A(k) NOD mice |
| Q42375749 | Exacerbation of Autoimmune Thyroiditis by CTLA-4 Blockade: A Role for IFNγ-Induced Indoleamine 2, 3-Dioxygenase. |
| Q36371424 | Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. |
| Q58006371 | Functional variants in SUMO4, TAB2 and NFκB and the risk of type 1 diabetes |
| Q39832919 | GAD65-Specific Cytotoxic T Lymphocytes Mediate Beta-Cell Death and Loss of Function |
| Q37359004 | Gene-gene interactions in the NOD mouse model of type 1 diabetes. |
| Q46103427 | Genes Outside the Major Histocompatibility Complex Locus Are Linked to the Development of Thyroid Autoantibodies and Thyroiditis in NOD.H2h4 Mice |
| Q52923466 | Genes and environment as predisposing factors in autoimmunity: acceleration of spontaneous thyroiditis by dietary iodide in NOD.H2(h4) mice. |
| Q40980040 | Genetic analysis of autoimmune disease |
| Q80988573 | Genetic analysis of the LEW.1AR1-iddm rat: an animal model for spontaneous diabetes mellitus |
| Q28776047 | Genetic analysis of type 1 diabetes using whole genome approaches |
| Q33908371 | Genetic bases for common polygenic diseases |
| Q53639909 | Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region. |
| Q54003240 | Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcgammaRIIb and is not associated with loci controlling diabetes. |
| Q74045636 | Genetic control of diabetes progression |
| Q44524587 | Genetic control of non obese diabetic mice susceptibility to high-dose streptozotocin-induced diabetes |
| Q34993192 | Genetic control of susceptibility in clinical and experimental uveitis |
| Q26809987 | Genetic dissection of complex genetic factor involved in NIDDM of OLETF rat |
| Q35600184 | Genetic epidemiology of type 1 diabetes |
| Q44605945 | Genetic epidemiology of visceral leishmaniasis in northeastern Brazil |
| Q52716571 | Genetic interaction between two insulin-dependent diabetes susceptibility loci, Idd2 and Idd13, in determining immunoregulatory DN T cell proportion. |
| Q54117646 | Genetic linkage analysis of collagen-induced arthritis in the mouse. |
| Q41611518 | Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes |
| Q34118443 | Genetic predisposition to IDDM. |
| Q34376868 | Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models |
| Q35539005 | Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders |
| Q30473057 | Genetics of autoimmune diabetes in animal models |
| Q34005302 | Genetics of experimental allergic encephalomyelitis supports the role of T helper cells in multiple sclerosis pathogenesis |
| Q41099923 | Genetics of insulin-dependent diabetes mellitus |
| Q30883833 | Genome-wide end-sequenced BAC resources for the NOD/MrkTac() and NOD/ShiLtJ() mouse genomes |
| Q41504683 | Genome-wide microarray expression analysis of CD4+ T Cells from nonobese diabetic congenic mice identifies Cd55 (Daf1) and Acadl as candidate genes for type 1 diabetes. |
| Q36235501 | Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse |
| Q33894591 | Grafts of supplementary thymuses injected with allogeneic pancreatic islets protect nonobese diabetic mice against diabetes |
| Q35554609 | Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice. |
| Q77627706 | Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes |
| Q36367698 | Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self-antigen La (SS-B) permits induction of systemic autoimmunity in normal mice. |
| Q36402763 | Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization |
| Q35764934 | Host modifier genes affect mouse autoimmunity induced by the lpr gene |
| Q34327412 | Humanin: a harbinger of mitochondrial-derived peptides? |
| Q39777306 | IFN-gamma, IGIF, and IDDM. |
| Q59804785 | IFNγ-Induced MHC Class II Expression on Islet Endothelial Cells Is an Early Marker of Insulitis but Is Not Required for Diabetogenic CD4+ T Cell Migration |
| Q35043426 | IL-13Rα1 expression on β-cell-specific T cells in NOD mice |
| Q34118450 | Immune mechanisms that regulate susceptibility to autoimmune type I diabetes |
| Q41578264 | Immunogenetics and the cause of autoimmune disease |
| Q46830266 | Impairment of NK cell function by NKG2D modulation in NOD mice |
| Q36375838 | In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes |
| Q71815062 | Induction of diabetes in standard mice by immunization with the p277 peptide of a 60‐kDa heat shock protein |
| Q37189659 | Influence of fecal sample storage on bacterial community diversity. |
| Q37358724 | Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55. |
| Q71046915 | Insulin-dependent diabetes mellitus |
| Q41373877 | Insulin-dependent diabetes mellitus: the hypothesis of molecular mimicry between islet cell antigens and microorganisms |
| Q35147719 | Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice |
| Q34568588 | Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. |
| Q33731408 | Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes |
| Q37163453 | Interleukin-21 is required for the development of type 1 diabetes in NOD mice |
| Q45818945 | Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 Diabetes |
| Q77658430 | Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens |
| Q60787773 | Localization of two insulin-dependent diabetes (Idd) genes to the Idd10 region on mouse Chromosome 3 |
| Q33814941 | MHC structure and autoimmune T cell repertoire development |
| Q36400215 | Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities |
| Q74836796 | Major histocompatibility complex-based suppression: a mechanism for T-cell control |
| Q42951792 | Major histocompatibility complex-linked control of autoimmunity |
| Q37379428 | Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice. |
| Q34333252 | Mapping of genes involved in murine herpes simplex virus keratitis: identification of genes and their modifiers |
| Q57632624 | Mapping of the murine type 1 diabetes locus Idd20 by genetic interaction |
| Q48070912 | Mapping the diabetes polygene Idd3 on mouse chromosome 3 by use of novel congenic strains |
| Q33923377 | Maternal obesity exacerbates insulitis and type 1 diabetes in non-obese diabetic mice |
| Q33729648 | Maternal obesity induces gut inflammation and impairs gut epithelial barrier function in nonobese diabetic mice |
| Q38691482 | Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation |
| Q37007219 | Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases. |
| Q44189001 | Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II. |
| Q41695556 | Molecular mimicry and the pathogenesis of insulin-dependent diabetes mellitus: still just an attractive hypothesis |
| Q36123986 | Molecular network-based analysis of guizhi-shaoyao-zhimu decoction, a TCM herbal formula, for treatment of diabetic peripheral neuropathy |
| Q34737266 | Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells |
| Q39182534 | Molecular therapy for renal diseases |
| Q35587450 | Mouse Models of Primary Sjogren's Syndrome |
| Q37737987 | Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease |
| Q35823975 | Mouse models of type 1 and type 2 diabetes derived from the same closed colony: genetic susceptibility shared between two types of diabetes |
| Q40930109 | Multifactorial inheritance in type 1 diabetes |
| Q38485977 | Mycobacteria, an environmental enhancer of lupus nephritis in a mouse model of systemic lupus erythematosus |
| Q36238069 | NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis |
| Q70869830 | Na+/H+ exchanger-1 alleles: strain distribution and correlation with activity |
| Q33220897 | Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity |
| Q36838170 | Nearby Construction Impedes the Progression to Overt Autoimmune Diabetes in NOD Mice. |
| Q35539035 | Neuronal elements in the pathogenesis of type 1 diabetes |
| Q36853632 | New tools for defining the 'genetic background' of inbred mouse strains |
| Q35926029 | Non-classical MHC I-E negatively regulates macrophage activation and Th17 cell development in NOD mice |
| Q34355712 | Organ-specific autoimmune disease: a deficiency of tolerogenic stimulation |
| Q71838378 | Organ-specific disease provoked by systemic autoimmunity |
| Q30481410 | PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice |
| Q41170315 | Panning for gold: genome-wide scanning for linkage in type 1 diabetes |
| Q82819211 | Parameters influencing antigen-specific immunotherapy for Type 1 diabetes |
| Q81429723 | Parameters influencing antigen-specific immunotherapy for type 1 diabetes |
| Q33849632 | Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice |
| Q47575059 | Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction. |
| Q35897397 | Postnatal Hematopoiesis and Gut Microbiota in NOD Mice Deviate from C57BL/6 Mice |
| Q34051981 | Practical approaches to determining disease-susceptible loci in multigenic autoimmune models |
| Q73822396 | Prediction and prevention of IDDM |
| Q73043307 | Prevention of autoimmune diabetes mellitus in NOD mice by transgenic expression of soluble tumor necrosis factor receptor p55 |
| Q45874299 | Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I. |
| Q37532745 | Prevention of type 1 diabetes by gene therapy |
| Q59851901 | Production of congenic mouse strains carrying NOD-derived diabetogenic genetic intervals: An approach for the genetic dissection of complex traits |
| Q40346082 | Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk |
| Q33911738 | Properties of HLA class II molecules divergently associated with Goodpasture's disease |
| Q35928288 | Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically |
| Q35129211 | Protective effects of combined intervention with adenovirus vector mediated IL-10 and IGF-1 genes on endogenous islet β cells in nonobese diabetes mice with onset of type 1 diabetes mellitus |
| Q41628477 | Questions about NOD mouse diabetes |
| Q32077931 | Receptor polymorphisms and diseases |
| Q36380639 | Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice |
| Q46543761 | Regulation by non-major histocompatibility complex genes of the allo-4-hydroxy-phenylpyruvate dioxygenase (F liver protein) response |
| Q35634096 | Resistance of the target islet tissue to autoimmune destruction contributes to genetic susceptibility in Type 1 diabetes |
| Q34035323 | Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice |
| Q73505005 | Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells |
| Q36825707 | Rodent models for investigating the dysregulation of immune responses in type 1 diabetes |
| Q46352165 | Selecting highly sensitive non-obese diabetic mice for improving the study of Sjögren's syndrome |
| Q74268389 | Selecting killers: the line between life and death |
| Q33942096 | Self-tolerance and the composition of T cell repertoire |
| Q74301355 | Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis |
| Q41782901 | Status of autoimmune diabetes 20-year after generation of BDC2.5-TCR transgenic non-obese diabetic mouse |
| Q27632133 | Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes |
| Q73336570 | Substitution of aspartic acid at beta57 with alanine alters MHC class II peptide binding activity but not protein stability: HLA-DQ (alpha1*0201, beta1*0302) and (alpha1*0201, beta1*0303) |
| Q35919777 | Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity |
| Q83205902 | T cells to a dominant epitope of GAD65 express a public CDR3 motif |
| Q58061432 | T cell–mediated exocrine pancreatic damage in major histocompatibility complex class II–deficient mice |
| Q40741831 | Target cell defense prevents the development of diabetes after viral infection. |
| Q41522431 | Temporal discontinuities in progression of NOD autoimmune diabetes. |
| Q40049468 | The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice |
| Q42166847 | The Idd6.2 diabetes susceptibility region controls defective expression of the Lrmp gene in nonobese diabetic (NOD) mice |
| Q39030606 | The Influence of the Microbiome on Type 1 Diabetes |
| Q55025713 | The Modulatory Roles of N-glycans in T-Cell-Mediated Autoimmune Diseases. |
| Q37056344 | The NKG2D receptor: immunobiology and clinical implications. |
| Q54041415 | The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. |
| Q41628470 | The NOD mouse |
| Q47434283 | The Type 1 Diabetes-Resistance Locus Idd22 Controls Trafficking of Autoreactive CTLs into the Pancreatic Islets of NOD Mice |
| Q57462025 | The genetic control of sialadenitis versus arthritis in a NOD.Q×B10.Q F2 cross |
| Q33955215 | The genetics of Graves' disease |
| Q34348977 | The genetics of complex autoimmune diseases: non-MHC susceptibility genes |
| Q36401834 | The influence of the NOD Nss1/Idd5 loci on sialadenitis and gene expression in salivary glands of congenic mice. |
| Q36287487 | The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection |
| Q35539014 | The non obese diabetic (NOD) mouse: a unique model for understanding the interaction between genetics and T cell responses |
| Q36889364 | The non-obese diabetic mouse sequence, annotation and variation resource: an aid for investigating type 1 diabetes |
| Q34452348 | The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. |
| Q38110933 | The potential role of dendritic cells in the therapy of Type 1 diabetes |
| Q34389136 | The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene |
| Q73205341 | The role of Fas in autoimmune diabetes |
| Q36736188 | The target tissue in autoimmunity--an influential niche |
| Q34713677 | The vertebrate genome annotation (Vega) database |
| Q35086645 | Thymic nurse cells: a microenvironment for thymocyte development and selection |
| Q46082790 | Thymic skewing of the CD4/CD8 ratio maps with the T-cell receptor alpha-chain locus |
| Q44625289 | Transcriptional Regulation of Type I Diabetes by NF-κB |
| Q36399452 | Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice |
| Q84654613 | Transgenic expression of haem oxygenase-1 in pancreatic beta cells protects non-obese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation |
| Q33944690 | Transgenic rescue implicates beta2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice |
| Q34141921 | Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis |
| Q74434006 | Type 1 diabetes |
| Q37098079 | Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment. |
| Q34498188 | Understanding autoimmune diabetes: insights from mouse models. |
| Q42489563 | Unique ultrastructure of exorbital lacrimal glands in male NOD and BALB/c mice. |
| Q36852657 | Usefulness of mouse models to study the pathogenesis of Sjögren's syndrome |
| Q39843532 | Validated germline-competent embryonic stem cell lines from nonobese diabetic mice |
| Q90008159 | What Have Slow Progressors Taught Us About T1D-Mind the Gap! |
| Q35878811 | What can the HLA transgenic mouse tell us about autoimmune diabetes? |
| Q36284342 | Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease |
| Q36368211 | pH-dependent peptide binding properties of the type I diabetes-associated I-Ag7 molecule: rapid release of CLIP at an endosomal pH. |
Search more.